Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanhao Jiang

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Pharmaceutics|January 31, 2023
Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapyWenpan Li, Yanhao Jiang, Jianqin Lu
Pharmaceutics|January 23, 2024
Lipid-Based Nanotechnology: LiposomeYanhao Jiang, Wenpan Li, Zhiren Wang, et al.
Chemical Science|May 13, 2026
Artificial recombinant high-density protein nanocarriers for precision drug deliveryWenpan Li, Nan Jia, Mengwen Li, et al.
Talanta|May 1, 2023
Chromatographic separation performance of silica microspheres surface-modified with triazine-containing imine-linked covalent organic frameworksHaoyu Long, Yanhao Jiang, Yanjuan Liu, et al.
Nature Communications|April 28, 2026
Boosting immunogenic tumour cell death via nanotherapeutic targeting of the Stanniocalcin 1 phagocytosis checkpoint for enhanced cancer immunotherapyWenpan Li, Zhiren Wang, Mengwen Li, et al.
Biomaterials|February 3, 2024
Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Communications|March 7, 2024
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic deliveryZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Communications|November 9, 2023
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Acta Biomaterialia|May 16, 2025
Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32Yanhao Jiang, Zhiren Wang, Wenpan Li, et al.
Nature Cancer|August 21, 2025
A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancerZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Pharmaceutics|January 31, 2023
Nanotechnology-enabled immunogenic cell death for improved cancer immunotherapyWenpan Li, Yanhao Jiang, Jianqin Lu
Pharmaceutics|January 23, 2024
Lipid-Based Nanotechnology: LiposomeYanhao Jiang, Wenpan Li, Zhiren Wang, et al.
Chemical Science|May 13, 2026
Artificial recombinant high-density protein nanocarriers for precision drug deliveryWenpan Li, Nan Jia, Mengwen Li, et al.
Talanta|May 1, 2023
Chromatographic separation performance of silica microspheres surface-modified with triazine-containing imine-linked covalent organic frameworksHaoyu Long, Yanhao Jiang, Yanjuan Liu, et al.
Nature Communications|April 28, 2026
Boosting immunogenic tumour cell death via nanotherapeutic targeting of the Stanniocalcin 1 phagocytosis checkpoint for enhanced cancer immunotherapyWenpan Li, Zhiren Wang, Mengwen Li, et al.
Biomaterials|February 3, 2024
Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Communications|March 7, 2024
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic deliveryZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Nature Communications|November 9, 2023
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapyZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Acta Biomaterialia|May 16, 2025
Enhanced delivery of camptothecin to colorectal carcinoma using a tumor-penetrating peptide targeting p32Yanhao Jiang, Zhiren Wang, Wenpan Li, et al.
Nature Cancer|August 21, 2025
A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancerZhiren Wang, Wenpan Li, Yanhao Jiang, et al.
Pageof 1